IOL Chemicals and Pharmaceuticals Limited - Balance (Quarterly)

IOL Chemicals and Pharmaceuticals Limited
IN ˙ BSE
89,00 ₹ ↓ -3,61 (-3,90%)
2026-04-24
DEL PRIS
Balance (Quarterly)

IOL Chemicals and Pharmaceuticals Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 3.112 32 608 14 587 77 1.509 782 1.683
Ændring (%) -98,96 1.781,11 -97,71 4.123,74 -86,90 1.862,03 -48,19 115,30
Aktiver Nuværende 10.782 10.808 9.794 9.204 9.193 11.198 10.857 11.513 11.406
Ændring (%) 0,24 -9,38 -6,02 -0,11 21,80 -3,04 6,05 -0,93
Aktiver 17.640 19.623 20.110 20.221 20.814 22.444 22.651 23.821 24.131
Ændring (%) 11,24 2,48 0,55 2,93 7,83 0,92 5,16 1,30
Forpligtelser 4.186 5.700 5.690 5.144 4.917 6.329 6.058 6.944 6.618
Ændring (%) 36,16 -0,18 -9,59 -4,42 28,72 -4,28 14,62 -4,70
Egenkapital 13.454 13.923 14.421 15.077 15.897 16.115 16.593 16.877 17.513
Ændring (%) 3,49 3,58 4,55 5,44 1,37 2,96 1,71 3,77
Passiver og Aktiekapital 17.640 19.623 20.110 20.221 20.814 22.444 22.651 23.821 24.131
Ændring (%) 11,24 2,48 0,55 2,93 7,83 0,92 5,16 1,30

Source: Capital IQ

Other Listings
IN:IOLCP 89,00 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista